- Consumer Products
- Latest 13.99
- Currency US$
- Change -0.27
- Percent Change -1.893 %
- Volume 1,244,480
- Thu Apr 17, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Dec 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Feb 11||$-0.09||May 14||$-0.11|
12 months ended Apr 19, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Sangamo BioSciences, Inc. is a leader in the development of novel transcription factors for the regulation of gene expression. Transcription factors are proteins that turn genes on or off by recognizing specific DNA sequences. The Universal Gene Recognition technology platform enables the engineering of a class of transcription factors known as zinc finger DNA binding proteins.